Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Bahrain Medical Bulletin. 2018; 40 (4): 230-233
in English | IMEMR | ID: emr-201744

ABSTRACT

Background: Simulated Patient Case [SPC] software is a powerful educational tool used in several medical colleges to augment the clinical competence of students


Objective: To evaluate the impact of this software on the clinical competence of medical students


Design: A Prospective Pilot Study


Setting: Arabian Gulf University, Bahrain


Method: One hundred five fifth-year medical students attending internal medicine clerkship were divided into two groups: 43 [41%] students used the DXR software [group A] and 62 [59%] students did not use the software [group B]. The grades obtained at the end of clerkship examination of the students who used the SPC software [DXR] [group A] was compared to the grades of the students who did not use the software [group B]. In addition, we compared the performance of this cohort using DXR in year 4 with their grades at the end of clerkship examination. P-value of < 0.05 was


considered statistically significant


Result: Group A students performed better than group B at the end of the clerkship exam, which revealed that the differences in the mean scores were statistically significant [P-value < 0.030]. A positive correlation between the students DXR scores in year 4 and their grades in clerkship exam [year 5] was found. The correlations between the DxR [SPC] scores and the student's scores of different exam components [SAQs, OSCE, mid-rotation, bed-side and clinical exams] was statistically significant [P-value=0.01]


Conclusion: The beneficial effect of the DXR SPC software on clinical competence was revealed. Therefore, we recommend it for students' clerkship training

2.
Bahrain Medical Bulletin. 2017; 39 (1): 33-37
in English | IMEMR | ID: emr-185650

ABSTRACT

Background: Bone pain frequency and optimal methods of vitamin D [VD] administration in adult patients with sickle cell anemia [SCA] are unclear


Objective: To assess bone pain frequency and level of VD in adult SCA patients after vitamin D medication


Setting: Salmaniya Medical Complex, Bahrain


Design: A Prospective Controlled Trial


Method: The study was performed from 1 January 2013 to 31 December 2014. Sixty-nine SCA patients were studied and compared with an age and gender-matched control group. Bone pain frequency was assessed using Visual Analogue Scale [VAS]. Measurement of serum level of VD, parathormone [PTH], calcium and alkaline phosphatase [ALP] at baseline, one and three months after treatment. Vitamin D Deficiency [VDD] was defined as <50 nmol/L. The mean difference of biochemical and clinical parameters was compared using paired Student t-test


Result: Fifty-one [74%] patients from the study group and 14 [20.3%] patients from the control group had VDD. Twenty-six [37.7%] patients were treated with IM injection of 600,000 IU once and 25 [36.2%] were treated with oral capsule of 50,000 IU weekly. Patients on IM treatment had pain frequency of 56 episodes per month before treatment, which was reduced to 43 [P<0.05] after one month; further reduction to 34 episodes [P<0.01] was achieved after three months. Patients on oral medication had pain frequency of 57 episodes per month before treatment, which reduced to 50 episodes after one month [P<0.05] and 40 after 3 months [P<0.01]. Vitamin D level increased to 54.15 +/- 2.73 in one month compared to 19.55 +/- 9.63 nmol/ml [P<0.05] before treatment. Patients on oral medication had VD increment of 31.64 +/- 4.44 compared to 22.11 +/- 9.46 nmol/ml [P<0.05] after one month and 53.69 +/- 2.37 nmol/ml after three months [P<0.001]


Conclusion: Frequency of bone pain was reduced significantly in adult SCA patients with VDD after one month of treatment of vitamin D3 injection with normalization of serum level


Subject(s)
Adult , Adolescent , Female , Humans , Male , Young Adult , Cholecalciferol/administration & dosage , Anemia, Sickle Cell/drug therapy , Homozygote , Adult , Pain/drug therapy , Bahrain
SELECTION OF CITATIONS
SEARCH DETAIL